1. Home
  2. NRXP vs TPCS Comparison

NRXP vs TPCS Comparison

Compare NRXP & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • TPCS
  • Stock Information
  • Founded
  • NRXP 2015
  • TPCS 1956
  • Country
  • NRXP United States
  • TPCS United States
  • Employees
  • NRXP N/A
  • TPCS N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • TPCS Metal Fabrications
  • Sector
  • NRXP Health Care
  • TPCS Industrials
  • Exchange
  • NRXP Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • NRXP 58.5M
  • TPCS 51.4M
  • IPO Year
  • NRXP N/A
  • TPCS N/A
  • Fundamental
  • Price
  • NRXP $3.58
  • TPCS $5.47
  • Analyst Decision
  • NRXP Strong Buy
  • TPCS
  • Analyst Count
  • NRXP 5
  • TPCS 0
  • Target Price
  • NRXP $31.40
  • TPCS N/A
  • AVG Volume (30 Days)
  • NRXP 416.8K
  • TPCS 30.5K
  • Earning Date
  • NRXP 11-13-2025
  • TPCS 08-21-2025
  • Dividend Yield
  • NRXP N/A
  • TPCS N/A
  • EPS Growth
  • NRXP N/A
  • TPCS N/A
  • EPS
  • NRXP N/A
  • TPCS N/A
  • Revenue
  • NRXP N/A
  • TPCS $33,424,000.00
  • Revenue This Year
  • NRXP N/A
  • TPCS N/A
  • Revenue Next Year
  • NRXP $395.09
  • TPCS N/A
  • P/E Ratio
  • NRXP N/A
  • TPCS N/A
  • Revenue Growth
  • NRXP N/A
  • TPCS 3.78
  • 52 Week Low
  • NRXP $1.10
  • TPCS $2.05
  • 52 Week High
  • NRXP $6.01
  • TPCS $6.25
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 67.97
  • TPCS 55.73
  • Support Level
  • NRXP $3.19
  • TPCS $5.18
  • Resistance Level
  • NRXP $3.84
  • TPCS $5.67
  • Average True Range (ATR)
  • NRXP 0.22
  • TPCS 0.20
  • MACD
  • NRXP 0.05
  • TPCS -0.01
  • Stochastic Oscillator
  • NRXP 70.87
  • TPCS 68.86

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

Share on Social Networks: